110 related articles for article (PubMed ID: 1564836)
21. Inhibitory effects of interleukin-4 on human renal cell carcinoma cells in vitro: in combination with interferon-alpha, tumor necrosis factor-alpha or interleukin-2.
Cheon J; Chung DJ; Kim JJ; Koh SK; Sohn J
Int J Urol; 1996 May; 3(3):196-201. PubMed ID: 8776617
[TBL] [Abstract][Full Text] [Related]
22. Chemokine gene expression in the murine renal cell carcinoma, RENCA, following treatment in vivo with interferon-alpha and interleukin-2.
Sonouchi K; Hamilton TA; Tannenbaum CS; Tubbs RR; Bukowski R; Finke JH
Am J Pathol; 1994 Apr; 144(4):747-55. PubMed ID: 8160774
[TBL] [Abstract][Full Text] [Related]
23. Differential sensitivity of renal cell carcinoma xenografts towards therapy with interferon-alpha, interferon-gamma, tumor necrosis factor and their combinations.
Beniers AJ; van Moorselaar RJ; Peelen WP; Debruyne FM; Schalken JA
Urol Res; 1991; 19(2):91-8. PubMed ID: 1906659
[TBL] [Abstract][Full Text] [Related]
24. [Anti-neoplastic activity of a human recombinant tumor necrosis factor (Hu-rec-TNF) alone or in combination with human recombinant gamma-interferon, doxorubicin or cis-platinum on a human renal cell carcinoma line].
Gohji K; Hamami G; Kamidono S
Hinyokika Kiyo; 1987 Mar; 33(3):329-35. PubMed ID: 3113191
[TBL] [Abstract][Full Text] [Related]
25. [Studies on the production of endogenous cytokines in patients with renal cell carcinoma].
Nakashima J; Tachibana M; Baba S; Deguchi N; Jitsukawa S; Hata M; Tazaki H
Nihon Hinyokika Gakkai Zasshi; 1992 Jul; 83(7):1110-7. PubMed ID: 1507728
[TBL] [Abstract][Full Text] [Related]
26. The effect of alpha and gamma interferon on cell growth and histocompatibility antigen expression by human renal carcinoma cells in vitro.
Angus R; Collins CM; Symes MO
Eur J Cancer; 1993; 29A(13):1879-85. PubMed ID: 8260246
[TBL] [Abstract][Full Text] [Related]
27. [The in vitro assessment of various types of interferons for urological tumors by the human tumor clonogenic assay].
Matsuyama H
Hinyokika Kiyo; 1986 Apr; 32(4):503-11. PubMed ID: 2426930
[TBL] [Abstract][Full Text] [Related]
28. The prognostic significance of immune changes in patients with renal cancer and melanoma treated with interferon-alpha 2b.
Tsavaris N; Baxevanis K; Kosmidis P; Papamichael M
Tumour Biol; 1995; 16(6):365-73. PubMed ID: 7569683
[TBL] [Abstract][Full Text] [Related]
29. Interleukin 4 alone and with gamma-interferon or alpha-tumor necrosis factor inhibits cell growth and modulates cell surface antigens on human renal cell carcinomas.
Hoon DS; Okun E; Banez M; Irie RF; Morton DL
Cancer Res; 1991 Oct; 51(20):5687-93. PubMed ID: 1913686
[TBL] [Abstract][Full Text] [Related]
30. Effect of biological response modifiers on growth and cell proliferation of human tumor xenografts in nude mice.
Maurer-Schultze B; Bassukas ID; Hofmockel G
Cell Mol Biol (Noisy-le-grand); 1995 Feb; 41(1):65-78. PubMed ID: 7773138
[TBL] [Abstract][Full Text] [Related]
31. Antiproliferative and cytotoxic effects of single and combined treatment with tumor necrosis factor alpha and/or alpha interferon on a human renal cell carcinoma xenotransplanted into nu/nu mice: cell kinetic studies.
Baisch H; Otto U; Klöppel G
Cancer Res; 1990 Oct; 50(19):6389-95. PubMed ID: 2400997
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
Hillman GG; Younes E; Visscher D; Hamzavi F; Kim S; Lam JS; Montecillo EJ; Ali E; Pontes JE; Puri RK; Haas GP
Clin Cancer Res; 1997 Oct; 3(10):1799-806. PubMed ID: 9815566
[TBL] [Abstract][Full Text] [Related]
33. Influence of immunotherapy (IL2 + LAK + inhibition of prostaglandin synthesis) on peripheral blood immune parameters and in vitro cytokine production in metastatic renal cell carcinoma.
Kleinknecht S; Bichler KH; Strohmaier WL
Urol Int; 1993; 50(3):121-8. PubMed ID: 8465478
[TBL] [Abstract][Full Text] [Related]
34. A randomized phase II trial comparing two different sequence combinations of autologous vaccine and human recombinant interferon gamma and human recombinant interferon alpha2B therapy in patients with metastatic renal cell carcinoma: clinical outcome and analysis of immunological parameters.
Schwaab T; Heaney JA; Schned AR; Harris RD; Cole BF; Noelle RJ; Phillips DM; Stempkowski L; Ernstoff MS
J Urol; 2000 Apr; 163(4):1322-7. PubMed ID: 10737537
[TBL] [Abstract][Full Text] [Related]
35. Effects of interferon-alpha (IFN) on the expression of interleukin 1-beta (IL-1), interleukin 6 (IL-6), granulocyte-macrophage colony-stimulating factor (GM-CSF) and tumor necrosis factor-alpha (TNF) in acute myeloid leukemia (AML) blasts.
Sissolak G; Hoffbrand AV; Mehta AB; Ganeshaguru K
Leukemia; 1992 Nov; 6(11):1155-60. PubMed ID: 1434798
[TBL] [Abstract][Full Text] [Related]
36. [Study on the combined therapy of DNA-methyltransferase inhibitor and interferon-alpha/beta for mouse spontaneously arose renal cell carcinoma, and immunological mechanism induced by the therapy].
Onishi T; Ohishi Y; Goto H; Suzuki H; Asano K; Hatano T; Abe K; Tomita M; Imagawa K
Nihon Hinyokika Gakkai Zasshi; 1998 Oct; 89(10):828-35. PubMed ID: 9844399
[TBL] [Abstract][Full Text] [Related]
37. Significant antitumoral activity of cationic multilamellar liposomes containing human IFN-beta gene against human renal cell carcinoma.
Nakanishi H; Mizutani Y; Kawauchi A; Ukimura O; Shiraishi T; Hatano M; Mizuno M; Yoshida J; Miki T
Clin Cancer Res; 2003 Mar; 9(3):1129-35. PubMed ID: 12631618
[TBL] [Abstract][Full Text] [Related]
38. [Study of adoptive immunotherapy with lymphokine-activated killer (LAK) cells and interleukin-2 for metastatic renal cell carcinoma. I. Generation of LAK cells by incubation in serum-free medium].
Nomura K; Fujioka T
Nihon Hinyokika Gakkai Zasshi; 1993 May; 84(5):822-30. PubMed ID: 8320887
[TBL] [Abstract][Full Text] [Related]
39. [Experimental study of chemotherapy of renal cell carcinoma. 2. Combination effect of interferon and antitumor agents based on cell kinetic analysis].
Konami T
Hinyokika Kiyo; 1987 Jan; 33(1):15-26. PubMed ID: 3577963
[TBL] [Abstract][Full Text] [Related]
40. Interaction of retinoic acid and interferon in renal cancer cell lines.
Nanus DM; Geng Y; Shen R; Lai HK; Pfeffer SR; Pfeffer LM
J Interferon Cytokine Res; 2000 Sep; 20(9):787-94. PubMed ID: 11032398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
